APA (7th ed.) Citation

Silverberg, J. I., Gooderham, M., Katoh, N., Aoki, V., Pink, A. E., Binamer, Y., . . . Wollenberg, A. Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2). Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Silverberg, Jonathan I., et al. Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2). Adis, Springer Healthcare.

MLA (9th ed.) Citation

Silverberg, Jonathan I., et al. Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2). Adis, Springer Healthcare.